Similar Items

Cover Image

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Background: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapies for secondary prevention in patients with low-density lipoprotein cholesterol ≥70 mg/dL or non-high-density lipoprotein cholesterol ≥100 mg/dL despite maximum tolerated statin therapy. Such patien...

Full description

Saved in:
Bibliographic Details
Institution:Universidad EIA
Main Authors: Roe, Matthew T., Li, Qian H., Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Lopez-Jaramillo, Patricio, Lopes, Renato D., Louie, Michael J., Moriarty, Patrick M., Szarek, Michael, Vogel, Robert, White, Harvey D., Zeiher, Andreas M., Baccara-Dinet, Marie T., Steg, Gabriel, Schwartz, Gregory G., Everest
Format: Artículo de revista
Language:English
Published: Circulation 2019-11-05
Subjects:
Acute coronary syndrome
Alirocumab
Dyslipidemias
Guideline
Online Access:https://repositorio.udes.edu.co/handle/001/5711
Tags: Add Tag
No Tags, Be the first to tag this record!